Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the HR gene is linked to a rare form of hair loss with limb deformities.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

RCS-01 is safe and may help rejuvenate aging skin.

A new genetic mutation causing Xeroderma Pigmentosum was found in an 8-year-old girl, affecting her DNA repair.

Reduced plakoglobin and steroid abuse increase the risk of heart rhythm issues.

Specific RNA patterns are linked to alopecia areata.

New mutations in the hairless gene may cause hair loss and affect bone development.

3α, 17β-androstanediol-glucuronide is not a useful marker for androgen excess but may help monitor certain treatments.

Fzd2 is important for skin and hair development through various signaling ways.

RIPK1 inhibitors might help prevent alopecia areata.

Gene variant linked to prostate cancer, hormone levels, and hair loss.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Rat dermal papilla cells have unique properties and interact differently with their environment compared to other skin cells.

The HR protein's role as a repressor is essential for controlling hair growth.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

A new rat strain with a specific gene mutation causes hair loss and kidney issues.

Women with early onset androgenetic alopecia have worse lipid profiles.

Researchers fixed gene mutations causing a skin disease in stem cells, which then improved skin grafts in mice.

EF and PXE not closely related.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

ME1 and PPAR signaling may influence hair loss in androgenetic alopecia.

Human keratinocytes do not naturally respond to androgens.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Specific mutations in a receptor cause facial abnormalities and hair loss.

Ruxolitinib helped a patient with alopecia areata regrow hair.